- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
DarioHealth to Add Dexcom CGM to Digital Health Platform
This agreement enables the integration of data from Dexcom’s continuous glucose monitor (CGM) directly into DarioHealth's metabolic digital health tool, adding another layer of support.
DarioHealth announced recently that Dexcom’s continuous glucose monitor (CGM) would be added to its multi–chronic condition platform.
This agreement enables the integration of data from Dexcom CGMs directly into Dario's metabolic digital health tool, adding another layer of support.
The integration with Dexcom builds on the $30 million strategic collaboration it began last year with Sanofi US, said DarioHealth, which is seeking to expand the use of digital health tools to manage chronic conditions, metabolic conditions, and musculoskeletal conditions.
DarioHealth’s platform uses clinical, engagement, and behavioral data to adapt each user's experience over time. The company also has its own glucose smart meter.
"Nearly 2 million people use a continuous glucose monitor today, and the ability to capture that data in Dario's platform expands our ability to deliver a dynamic, highly relevant experience to more people living with diabetes. It's an exciting development that will ultimately benefit every Dario member as the CGM data enriches our overall data ecosystem," said Rick Anderson, president of DarioHealth, in a statement.
The digital health market is expected to reach $1.3 trillion by 2030, according to one report, with the surge in chronic diseases in the United States fueling the trend.
More than half of Americans have chronic conditions, which the CDC has said is one of the top drivers of health care costs. In addition, 4 in 10 Americans have 2 or more chronic conditions, including diabetes, chronic kidney disease, Alzheimer disease, stroke, heart disease, and cancer.
Diabetes, in particular, affects more than 37 million US individuals, creating a higher risk of heart disease, stroke, kidney failure, blindness, and amputation.
Reference
Dario partners to integrate Dexcom CGM data. News release. DarioHealth; February 8, 2023; accessed February 13, 2023. https://dariohealth.investorroom.com/2023-02-08-Dario-Partners-to-Integrate-Dexcom-CGM-Data
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Reaching Rural America: Value-Based Care Solutions for Systemic Health and Social Inequalities
March 7th 2023On this episode of Managed Care Cast, we speak with Jennifer Schneider, MD, co-founder and chief executive officer of Homeward, a value-based care provider aiming to improve access to high-quality care in rural communities through tech-enabled clinical services, partnerships with local physicians and health plans, and community-level demographic data.
Listen
